Menopause Tech & devices Clinician / health professional Business & startups

Longevitix launches women’s health extension to AI platform

By Published On: November 13, 2026
Longevitix launches women’s health extension to AI platform

Longevitix has launched new women’s health tools for its AI platform, designed to help physicians manage care during perimenopause and menopause.

The extension brings together medical records, laboratory results, imaging, wearable data and patient-reported symptoms to support clinical decisions.

According to the company, the technology interprets health information based on a woman’s life stage, symptoms and risk factors, helping clinicians identify areas that may need attention.

The platform covers more than 15 clinical domains, including seven focused on women’s health.

These include hormones and menstrual cycles, gynaecological and reproductive health, cancer screening, sexual health, pelvic and urinary health, hair and skin, and bone and muscle health.

Dr Neil Panchal, chief medical officer of Longevitix, said: “Women’s health requires looking beyond individual symptoms or isolated test results to understand the full picture of a patient’s health.

“During perimenopause and menopause, changes that affect sleep, mood, metabolism and bone health can be interconnected, yet they are often addressed separately.

“Our women’s health solution helps physicians connect the dots, interpret information in the context of each patient’s life stage, and make more informed decisions about prevention and personalised care.”

Patients can record symptoms in daily journals, allowing clinical teams to monitor their experiences and responses to treatment.

The platform also connects with wearable devices and services including Oura, Apple Health and Whoop.

Clinicians can review information such as sleep quality, overnight temperature and heart rate alongside other medical data.

The system provides information on lifestyle interventions, supplements, hormone therapy and medication options, including supporting research and expected effects.

Patients can access personalised reports and care plans through an accompanying app.

Longevitix describes its technology as a physician-led AI platform for preventive healthcare and longevity medicine.

It analyses patient information and suggests clinical insights and care plans, while physicians retain control over treatment decisions.

The platform also includes tools for collaboration between healthcare professionals and ongoing communication with patients between appointments.

Founded in early 2025 by Effie Arditi, Gaby Hayon and Panchal, Longevitix provides technology to clinicians working in preventive, longevity, functional and integrative medicine.

Targeted antibiotic treatment prevents recurrent UTIs
Flo Health achieves medical device quality certification